2015-004880-35
A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
GlaxoSmithKline Research & Development Ltd·EU Clinical Trials Register
Study focus
- Disease/Condition
- Migraine
Sponsor & location
- Primary sponsor
- GlaxoSmithKline Research & Development Ltd
- Funder
- GSK
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- Subject is < 30 kg.
ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2015-004880-35
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2015-004880-35 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.